Biodesix to Report Third Quarter 2022 Financial Results on November 3, 2022
businesswire.com
news
2022-10-20 00:00:00

October 20, 2022 06:00 AM Eastern Daylight Time BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, today announced that it will release financial results for the third quarter ended September 30, 2022 before the open of trading on Thursday, November 3. Biodesix's management will host a conference call and webcast to discuss its financial results and provide a general business update at 8:00 a.m. Eastern Time on the same day.
